Maher Masoud - 03 Jan 2024 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
MXCT
Transactions as of
03 Jan 2024
Net transactions value
$0
Form type
4
Filing time
04 Jan 2024, 16:30:10 UTC
Previous filing
21 Mar 2023
Next filing
10 Jun 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Employee Stock Option (right to buy) Award $0 +400,000 $0.000000 400,000 03 Jan 2024 Common Stock 400,000 $4.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option grant was made pursuant to the terms of the letter agreement, dated as of December 11, 2023, by and between the Issuer and the reporting person, entered into in connection with his appointment as President and Chief Executive Officer of the Issuer, as set forth in a Current Report on Form 8-K filed by the Issuer on December 11, 2023. Of the shares underlying the option, 25% will vest on January 2, 2025 and the remaining 75% will vest in 36 equal monthly installments thereafter, in each case subject to the reporting person's continuous service with the Issuer at the applicable vesting date.